Login / Signup
Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.
Xiaoqin Yang
Shunming Xu
Published in:
American journal of therapeutics (2024)
Keyphrases
</>
high glucose
diabetic rats
emergency department
stem cells
adverse drug
bone marrow
mesenchymal stem cells
cell therapy
electron transfer
replacement therapy